Hilton Capital Management, LLC Astrazeneca PLC Transaction History
Hilton Capital Management, LLC
- $1.08 Billion
- Q1 2025
A detailed history of Hilton Capital Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hilton Capital Management, LLC holds 156,893 shares of AZN stock, worth $11.3 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
156,893
Previous 155,317
1.01%
Holding current value
$11.3 Million
Previous $10.2 Million
13.32%
% of portfolio
1.06%
Previous 0.93%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
507MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.1 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.92 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.56 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.29 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.25 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...